{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein (a-Syn) has attracted considerable attention due to its involvement in Parkinson's disease (PD), characterized by the selective and progressive loss of dopaminergic neurons... Three missense mutations for a-Syn, A30P, A53T, and E46K have been known to be associated with rare autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism of Parkinson's disease (PD) as involving the loss of dopaminergic neurons and the formation of Lewy bodies, with a-Synuclein mutations like A30P linked to familial PD through aggregation and neurotoxicity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We assessed the gene-environment interaction in an in vitro PD model, by subjecting dopaminergic SH-SY5Y cells stably overexpressing wild type (wt), A30P, A53T or E46K a-Syn to acute or chronic rotenone and maneb treatment... MTT assay, ROS measurement, and mitochondrial membrane potential (C m) were evaluated.",
          "judgment": "Yes",
          "reasoning": "The general class of assays used (MTT for cell viability, ROS measurement for oxidative stress, and mitochondrial membrane potential assessment) are relevant to PD pathogenesis as they model neuronal cell death, oxidative stress, and mitochondrial dysfunction, which are central to PD mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Untransfected and mock-transfected cells served as controls... All data are expressed as means ± S.E.M of 3 independent experiments.",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls (untransfected and mock-transfected cells as negative/wild-type controls) and explicitly states the use of replicates (3 independent experiments), meeting both conditions for basic controls and replicates.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "SH-SY5Y cells stably expressing wt and mutant a-Syn (A30P, A53T, E46K) were established... wt a-Syn attenuated rotenone and maneb-induced cell death, whereas the mutant a-Syn constructs exacerbated environmental toxins-induced cytotoxicity.",
          "judgment": "Yes",
          "reasoning": "Wild-type a-Syn serves as a benign control, while the mutants A30P, A53T, and E46K are known pathogenic variants associated with familial PD, satisfying the condition of using known pathogenic and benign variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analysis was performed using one-way-ANOVA. A p value of less than 0.05 was considered as statistically significant... Data is expressed as percent of survival compared to untreated untransfected SH-SY5Y cells.",
          "judgment": "No",
          "reasoning": "While statistical analysis (one-way ANOVA) is performed with p-values reported, there is no direct calculation or estimation of OddsPath or equivalent quantitative measure of pathogenicity likelihood for the functional data specific to A30P.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "SH-SY5Y cells overexpressing wild type or familial a-Syn mutants (A30P, E46K, and A53T) were subjected to treatments... wt a-Syn as benign control and three mutants as pathogenic controls.",
          "judgment": "Less than or equal to 10 total controls",
          "reasoning": "The study uses wild-type a-Syn as a benign control and three mutant variants (A30P, A53T, E46K) as pathogenic controls, totaling 4 variant controls, which is less than or equal to 10.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for SNCA A30P is rated as PS3_supporting due to relevant assays demonstrating increased neurotoxicity and ROS production compared to wild-type, supported by basic controls and replicates, and the use of variant controls. However, the lack of OddsPath calculation and limited number of variant controls (4 total) restricts the strength to supporting."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein (a-Syn) has attracted considerable attention due to its involvement in Parkinson's disease (PD), characterized by the selective and progressive loss of dopaminergic neurons... Three missense mutations for a-Syn, A30P, A53T, and E46K have been known to be associated with rare autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism of Parkinson's disease (PD) as involving the loss of dopaminergic neurons and the formation of Lewy bodies, with a-Synuclein mutations like A53T linked to familial PD through aggregation and neurotoxicity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We assessed the gene-environment interaction in an in vitro PD model, by subjecting dopaminergic SH-SY5Y cells stably overexpressing wild type (wt), A30P, A53T or E46K a-Syn to acute or chronic rotenone and maneb treatment... MTT assay, ROS measurement, and mitochondrial membrane potential (C m) were evaluated.",
          "judgment": "Yes",
          "reasoning": "The general class of assays used (MTT for cell viability, ROS measurement for oxidative stress, and mitochondrial membrane potential assessment) are relevant to PD pathogenesis as they model neuronal cell death, oxidative stress, and mitochondrial dysfunction, which are central to PD mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Untransfected and mock-transfected cells served as controls... All data are expressed as means ± S.E.M of 3 independent experiments.",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls (untransfected and mock-transfected cells as negative/wild-type controls) and explicitly states the use of replicates (3 independent experiments), meeting both conditions for basic controls and replicates.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "SH-SY5Y cells stably expressing wt and mutant a-Syn (A30P, A53T, E46K) were established... wt a-Syn attenuated rotenone and maneb-induced cell death, whereas the mutant a-Syn constructs exacerbated environmental toxins-induced cytotoxicity.",
          "judgment": "Yes",
          "reasoning": "Wild-type a-Syn serves as a benign control, while the mutants A30P, A53T, and E46K are known pathogenic variants associated with familial PD, satisfying the condition of using known pathogenic and benign variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analysis was performed using one-way-ANOVA. A p value of less than 0.05 was considered as statistically significant... Data is expressed as percent of survival compared to untreated untransfected SH-SY5Y cells.",
          "judgment": "No",
          "reasoning": "While statistical analysis (one-way ANOVA) is performed with p-values reported, there is no direct calculation or estimation of OddsPath or equivalent quantitative measure of pathogenicity likelihood for the functional data specific to A53T.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "SH-SY5Y cells overexpressing wild type or familial a-Syn mutants (A30P, E46K, and A53T) were subjected to treatments... wt a-Syn as benign control and three mutants as pathogenic controls.",
          "judgment": "Less than or equal to 10 total controls",
          "reasoning": "The study uses wild-type a-Syn as a benign control and three mutant variants (A30P, A53T, E46K) as pathogenic controls, totaling 4 variant controls, which is less than or equal to 10.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for SNCA A53T is rated as PS3_supporting due to relevant assays demonstrating increased neurotoxicity and ROS production compared to wild-type, supported by basic controls and replicates, and the use of variant controls. However, the lack of OddsPath calculation and limited number of variant controls (4 total) restricts the strength to supporting."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Synuclein (a-Syn) has attracted considerable attention due to its involvement in Parkinson's disease (PD), characterized by the selective and progressive loss of dopaminergic neurons... Three missense mutations for a-Syn, A30P, A53T, and E46K have been known to be associated with rare autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism of Parkinson's disease (PD) as involving the loss of dopaminergic neurons and the formation of Lewy bodies, with a-Synuclein mutations like E46K linked to familial PD through aggregation and neurotoxicity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We assessed the gene-environment interaction in an in vitro PD model, by subjecting dopaminergic SH-SY5Y cells stably overexpressing wild type (wt), A30P, A53T or E46K a-Syn to acute or chronic rotenone and maneb treatment... MTT assay, ROS measurement, and mitochondrial membrane potential (C m) were evaluated.",
          "judgment": "Yes",
          "reasoning": "The general class of assays used (MTT for cell viability, ROS measurement for oxidative stress, and mitochondrial membrane potential assessment) are relevant to PD pathogenesis as they model neuronal cell death, oxidative stress, and mitochondrial dysfunction, which are central to PD mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Untransfected and mock-transfected cells served as controls... All data are expressed as means ± S.E.M of 3 independent experiments.",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls (untransfected and mock-transfected cells as negative/wild-type controls) and explicitly states the use of replicates (3 independent experiments), meeting both conditions for basic controls and replicates.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "SH-SY5Y cells stably expressing wt and mutant a-Syn (A30P, A53T, E46K) were established... wt a-Syn attenuated rotenone and maneb-induced cell death, whereas the mutant a-Syn constructs exacerbated environmental toxins-induced cytotoxicity.",
          "judgment": "Yes",
          "reasoning": "Wild-type a-Syn serves as a benign control, while the mutants A30P, A53T, and E46K are known pathogenic variants associated with familial PD, satisfying the condition of using known pathogenic and benign variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analysis was performed using one-way-ANOVA. A p value of less than 0.05 was considered as statistically significant... Data is expressed as percent of survival compared to untreated untransfected SH-SY5Y cells.",
          "judgment": "No",
          "reasoning": "While statistical analysis (one-way ANOVA) is performed with p-values reported, there is no direct calculation or estimation of OddsPath or equivalent quantitative measure of pathogenicity likelihood for the functional data specific to E46K.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "SH-SY5Y cells overexpressing wild type or familial a-Syn mutants (A30P, E46K, and A53T) were subjected to treatments... wt a-Syn as benign control and three mutants as pathogenic controls.",
          "judgment": "Less than or equal to 10 total controls",
          "reasoning": "The study uses wild-type a-Syn as a benign control and three mutant variants (A30P, A53T, E46K) as pathogenic controls, totaling 4 variant controls, which is less than or equal to 10.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for SNCA E46K is rated as PS3_supporting due to relevant assays demonstrating increased neurotoxicity and ROS production compared to wild-type, supported by basic controls and replicates, and the use of variant controls. However, the lack of OddsPath calculation and limited number of variant controls (4 total) restricts the strength to supporting."
    }
  ]
}